|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 28365 |
FusionGeneSummary for PPP1R2_CLDN1 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: PPP1R2_CLDN1 | Fusion gene ID: 28365 | Hgene | Tgene | Gene symbol | PPP1R2 | CLDN1 | Gene ID | 5504 | 9076 |
| Gene name | protein phosphatase 1 regulatory inhibitor subunit 2 | claudin 1 | |
| Synonyms | IPP-2|IPP2|PPP1R2A | CLD1|ILVASC|SEMP1 | |
| Cytomap | 3q29 | 3q28 | |
| Type of gene | protein-coding | protein-coding | |
| Description | protein phosphatase inhibitor 2phosphoprotein phosphatase | claudin-1senescence-associated epithelial membrane protein 1 | |
| Modification date | 20180523 | 20180519 | |
| UniProtAcc | P41236 | O95832 | |
| Ensembl transtripts involved in fusion gene | ENST00000328432, | ENST00000295522, | |
| Fusion gene scores | * DoF score | 3 X 2 X 3=18 | 3 X 3 X 2=18 |
| # samples | 3 | 3 | |
| ** MAII score | log2(3/18*10)=0.736965594166206 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(3/18*10)=0.736965594166206 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
| Context | PubMed: PPP1R2 [Title/Abstract] AND CLDN1 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| TCGA | LD | LUSC | TCGA-56-7223-01A | PPP1R2 | chr3 | 195256595 | - | CLDN1 | chr3 | 190030825 | - |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| Frame-shift | ENST00000328432 | ENST00000295522 | PPP1R2 | chr3 | 195256595 | - | CLDN1 | chr3 | 190030825 | - |
Top |
FusionProtFeatures for PPP1R2_CLDN1 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| PPP1R2 | CLDN1 |
| Inhibitor of protein-phosphatase 1. | Claudins function as major constituents of the tightjunction complexes that regulate the permeability of epithelia.While some claudin family members play essential roles in theformation of impermeable barriers, others mediate the permeabilityto ions and small molecules. Often, several claudin family membersare coexpressed and interact with each other, and this determinesthe overall permeability. CLDN1 is required to prevent theparacellular diffusion of small molecules through tight junctionsin the epidermis and is required for the normal barrier functionof the skin. Required for normal water homeostasis and to preventexcessive water loss through the skin, probably via an indirecteffect on the expression levels of other proteins, since CLDN1itself seems to be dispensable for water barrier formation inkeratinocyte tight junctions (PubMed:23407391).{ECO:0000269|PubMed:23407391}. (Microbial infection) Acts as a receptor for hepatitis Cvirus (HCV) in hepatocytes (PubMed:17325668, PubMed:20375010).Associates with CD81 and the CLDN1-CD81 receptor complex isessential for HCV entry into host cell (PubMed:20375010). Acts asa receptor for dengue virus (PubMed:24074594).{ECO:0000269|PubMed:17325668, ECO:0000269|PubMed:20375010,ECO:0000269|PubMed:24074594}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for PPP1R2_CLDN1 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for PPP1R2_CLDN1 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| PPP1R2 | PPP1CB, PPP1R9B, LMTK2, NEK2, PPP1CA, ELAVL1, TERF2IP, TINF2, PPP1CC, CIAPIN1, GSK3A, GSK3B, GINS4, ISOC1, DCPS, G6PD, MSN, NAE1, NCDN, NSFL1C, PDHA1, PDIA4, PRCP, PROSC, RAP1GDS1, TATDN1, TNFAIP8, TUFM, VCL, YWHAE, ZNF622, TP53BP2, PPP1R3A, PPP1R11, KDM2A, PDIA5, POLR2G, PPP1R7, SFN, SLK, SULT1C3, HIST1H2BG, EWSR1, THOC7, GTF2H5 | CLDN1 | CLDN3, INADL, TJP2, TJP1, TJP3, LNX1, DRG1 |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for PPP1R2_CLDN1 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for PPP1R2_CLDN1 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Tgene | CLDN1 | C1458155 | Mammary Neoplasms | 2 | CTD_human |
| Tgene | CLDN1 | C0007621 | Neoplastic Cell Transformation | 1 | CTD_human |
| Tgene | CLDN1 | C0011616 | Contact Dermatitis | 1 | CTD_human |
| Tgene | CLDN1 | C0014175 | Endometriosis | 1 | CTD_human |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|